Meeder Asset Management’s Kite Pharma, Inc. KITE Stock Holding History

Meeder Asset Management’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-356	Closed	-$64K	–	1916
2017 Q3	$64K	Buy	356 +301	+547%	+$41.9K	0.01%	644
2017 Q2	$6K	Buy	+55	New	+$4.49K	﹤0.01%	1175
2016 Q1	–	Sell	-4,204	Closed	-$259K	–	976
2015 Q4	$259K	Buy	+4,204	New	+$296K	0.02%	482

Meeder Asset Management's KITE Position: Q4 2017 in Review

Meeder Asset Management sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 356 shares — an estimated $64K sold.

Meeder Asset Management first reported a position in KITE in Q4 2015 and held it in 3 quarters. The position peaked at $259K in Q4 2015. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Meeder Asset Management reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Meeder Asset Management sold 356 Kite Pharma, Inc. shares in Q4 2017, an estimated $64K.
Meeder Asset Management first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 3 quarters.
Meeder Asset Management's Kite Pharma, Inc. position peaked at $259K in Q4 2015.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Meeder Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.